130 related articles for article (PubMed ID: 32149778)
1. Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Ganzleben I; Hirschmann S; Köhler J; Fuchs FS; Rieker RJ; Baer E; Klenske E; Nagore D; Neurath MF; Atreya R
Am J Gastroenterol; 2020 Apr; 115(4):632-634. PubMed ID: 32149778
[No Abstract] [Full Text] [Related]
2. Necrobiotic nodules: a rare pulmonary manifestion of Crohn's disease.
Sanjeevi A; Roy HK
Am J Gastroenterol; 2003 Apr; 98(4):941-3. PubMed ID: 12738489
[No Abstract] [Full Text] [Related]
3. Necrobiotic Pulmonary Nodules of Crohn's Disease in a Patient Receiving Vedolizumab.
Myc LA; Girton MR; Stoler MH; Davis EM
Am J Respir Crit Care Med; 2019 Jan; 199(1):e1-e2. PubMed ID: 30156859
[No Abstract] [Full Text] [Related]
4. Pulmonary necrobiotic nodules: a rare extraintestinal manifestation of Crohn's disease.
Warwick G; Leecy T; Silverstone E; Rainer S; Feller R; Yates DH
Eur Respir Rev; 2009 Mar; 18(111):47-50. PubMed ID: 20956123
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Necrobiotic Nodules: A Rare Manifestation of Crohn's Disease.
Larrey Ruiz L; Sabater Abad C; Peño Muñoz L; Huguet Malavés JM; Juan Samper G
Arch Bronconeumol (Engl Ed); 2019 Feb; 55(2):108-110. PubMed ID: 29884425
[No Abstract] [Full Text] [Related]
6. [Sweet's syndrome and erythema nodosum associated with Crohn's disease treated by infliximab].
Vanbiervliet G; Anty R; Schneider S; Arab K; Rampal P; Hebuterne X
Gastroenterol Clin Biol; 2002 Mar; 26(3):295-7. PubMed ID: 11981477
[No Abstract] [Full Text] [Related]
7. Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
Madarame A; Kimura H; Kunisaki R
J Crohns Colitis; 2020 May; 14(4):569-570. PubMed ID: 31616911
[No Abstract] [Full Text] [Related]
8. Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
Chateau T; Angioi K; Peyrin-Biroulet L
J Crohns Colitis; 2020 May; 14(4):571. PubMed ID: 31606743
[No Abstract] [Full Text] [Related]
9. Pleuritic Chest Pain in a 24-Year-Old Man with Crohn's Disease.
Rezik MM; Ouellette DR
Am J Respir Crit Care Med; 2016 Nov; 194(9):e12-e13. PubMed ID: 27413816
[No Abstract] [Full Text] [Related]
10. Dermatologic manifestations of Crohn disease in children: response to infliximab.
Kugathasan S; Miranda A; Nocton J; Drolet BA; Raasch C; Binion DG
J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):150-4. PubMed ID: 12883301
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.
García Cámara P; Zubiri Ara ML; García López S
Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905
[No Abstract] [Full Text] [Related]
12. Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.
Nunes G; Patita M; Fernandes V
J Crohns Colitis; 2019 May; 13(6):812-813. PubMed ID: 30535292
[No Abstract] [Full Text] [Related]
13. The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.
Narula N; Aruljothy A; Wong ECL; Homenauth R; Alshahrani AA; Marshall JK; Reinisch W
United European Gastroenterol J; 2021 Jun; 9(5):581-589. PubMed ID: 34077627
[TBL] [Abstract][Full Text] [Related]
14. Metastatic Cutaneous Crohn's Disease of the Face-A Case Successfully Treated With Ustekinumab.
Martins Figueiredo L; Oliveira AM; Martins A
J Crohns Colitis; 2020 Jul; 14(6):874-875. PubMed ID: 31630151
[No Abstract] [Full Text] [Related]
15. Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn's disease.
Freeman HJ; Davis JE; Prest ME; Lawson EJ
Can J Gastroenterol; 2004 Nov; 18(11):687-90. PubMed ID: 15565210
[TBL] [Abstract][Full Text] [Related]
16. Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study.
de Risi-Pugliese T; Seksik P; Bouaziz JD; Chasset F; Moguelet P; Gornet JM; Bourrier A; Amiot A; Beaugerie L; Francès C; Guégan S;
J Am Acad Dermatol; 2019 Mar; 80(3):781-784. PubMed ID: 30003991
[No Abstract] [Full Text] [Related]
17. [Ustekinumab for the treatment of Crohn's disease -Indication of Ustekinumab according to efficacy and safety].
Ishihara S; Kawashima K; Kinoshita Y
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(3):216-223. PubMed ID: 30853674
[No Abstract] [Full Text] [Related]
18. Anti-interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report.
Spagnuolo R; Dastoli S; Silvestri M; Cosco C; Garieri P; Bennardo L; Nisticò SP
Dermatol Ther; 2019 Mar; 32(2):e12811. PubMed ID: 30620119
[No Abstract] [Full Text] [Related]
19. [A case of Crohn's disease complicated by Guillain-Barrè syndrome during ustekinumab therapy].
Fukushima T; Nakajima K; Nozawa H; Nishino H; Sugita A; Koganei K; Futatsuki R; Yamaguchi S; Asano S; Matsushima M
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(4):324-329. PubMed ID: 30971669
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of refractory erythema nodosum associated with Crohn's disease using potassium iodide.
Marshall JK; Irvine EJ
Can J Gastroenterol; 1997 Sep; 11(6):501-2. PubMed ID: 9347164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
